Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
J Public Health (Oxf) ; 40(1): 163-168, 2018 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-28369595

RESUMO

Background: Hand hygiene (HH) has a low rate of adherence worldwide. This study aimed to estimate the HH adherence rate before and after the implementation of the multimodal strategy and to perform a self-assessment of an institution for promotion and practice of HH. Methods: Before and after study, conducted in a university hospital. Professionals of the medical and nursing staff were included. Data collection was from October 2013 to July 2015, through observations of the HH opportunities and application of the HH self-assessment instrument for the institution. Descriptive and univariate analysis were performed. Results: A total of 9500 HH opportunities were observed. The rate of adherence to HH in pre-intervention period was 20.8%, compared to 16.2% and 15.7% in post-intervention. Regarding the evaluation of the institution, it did not have an established ongoing program of training of professionals, no feedback of HH rates to professionals. Conclusion: The low rate of HH adherence reflected the evaluation of the institution in relation to its investment in the practice and promotion of HH, showing that the investment policy for HH adherence needs to be reviewed, considering that before the study the hospital has not been trained in the 'My Five Moments for HH'.


Assuntos
Fidelidade a Diretrizes , Higiene das Mãos , Recursos Humanos em Hospital , Brasil , Auditoria Clínica , Feminino , Hospitais Universitários , Humanos , Masculino
2.
Acta Psychiatr Scand ; 131(5): 360-8, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25401224

RESUMO

OBJECTIVE: The impact of childhood trauma (CT) on brain-derived neurotrophic factor (BDNF) and cytokines levels remains unclear. We investigated the association between CT and changes in BDNF and cytokines plasma levels in children. METHOD: We recruited 36 children with trauma (CT+) and 26 children without trauma (CT-). The presence of CT was based on a clinical interview and by Criteria A of DSM-IV criteria for PTSD. Blood samples were drawn from all children to assess BDNF and cytokines. ancova was performed with psychiatric symptoms and BMI as covariates to evaluate group differences in plasma levels. RESULTS: CT+ showed increased levels of BDNF and TNF-α after excluding children with history of inflammatory disease (P<0.05) when compared with those CT-. IL-12p70, IL-6, IL-8, IL-10, and IL-1ß levels were not statistically different between groups. CONCLUSION: CT+ showed increased BDNF and proinflammatory cytokines levels. The increase in BDNF levels may be an attempt to neutralize the negative effects of CT, while an increase in TNF-a levels be associated with a proinflammatory state after CT. How these changes associated with trauma relate to other biological changes and illness trajectory later in life remain to be further studied.


Assuntos
Fator Neurotrófico Derivado do Encéfalo/sangue , Maus-Tratos Infantis/psicologia , Citocinas/sangue , Transtornos de Estresse Pós-Traumáticos , Fator de Necrose Tumoral alfa/sangue , Biomarcadores/sangue , Criança , Manual Diagnóstico e Estatístico de Transtornos Mentais , Feminino , Humanos , Inflamação/sangue , Masculino , Psicopatologia , Transtornos de Estresse Pós-Traumáticos/sangue , Transtornos de Estresse Pós-Traumáticos/diagnóstico , Transtornos de Estresse Pós-Traumáticos/etiologia , Transtornos de Estresse Pós-Traumáticos/fisiopatologia
3.
Acta Psychiatr Scand ; 129(6): 437-44, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24628576

RESUMO

OBJECTIVE: There are several models of staging in bipolar disorder (BD), but none has been validated. The aims of this study were to empirically investigate clinical variables that may be useful to classify patients in clusters according to stage and study the association with biomarkers as biological validators. METHOD: This was a historical cohort study. Patients (n = 115) diagnosed with BD and not in an acute episode and first-degree relatives of patients diagnosed with BD (n = 25) were recruited. Sociodemographic, clinical, and functional data were collected. Serum cytokines, brain-derived neurotrophic factor, and biomarkers of lipid and protein oxidation were assessed. Cluster analysis was carried out to build a model of staging, and logistic regression was conducted to study associations between the model and biomarkers. RESULTS: Cluster analysis divided the sample into two equitable groups, denominated early and late stage, with empirical cutoffs for the Functioning Assessment Short Test score, number of episodes, age at onset of the disorder, and time elapsed since first episode. In the logistic regression, IL-6 was associated with late stage (P = 0.029). CONCLUSION: This study supports that clinical, functional, and biochemical variables may help to define a classification of staging in BD.


Assuntos
Transtorno Bipolar/diagnóstico , Interleucina-6/sangue , Adulto , Idade de Início , Transtorno Bipolar/sangue , Transtorno Bipolar/fisiopatologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Fatores de Tempo
4.
Acta Psychiatr Scand ; 130(5): 354-63, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24961757

RESUMO

OBJECTIVE: We discuss the rationale behind staging systems described specifically for bipolar disorders. Current applications, future directions and research gaps in clinical staging models for bipolar disorders are outlined. METHOD: We reviewed the literature pertaining to bipolar disorders, focusing on the first episode onwards. We systematically searched data on staging models for bipolar disorders and allied studies that could inform the concept of staging. RESULTS: We report on several dimensions that are relevant to staging concepts in bipolar disorder. We consider whether staging offers a refinement to current diagnoses by reviewing clinical studies of treatment and functioning and the potential utility of neurocognitive, neuroimaging and peripheral biomarkers. CONCLUSION: Most studies to date indicate that globally defined late-stage patients have a worse overall prognosis and poorer response to standard treatment, consistent with patterns for end-stage medical disorders. We believe it is possible at this juncture to speak broadly of 'early'- and 'late'-stage bipolar disorder. Next steps require further collaborative efforts to consider the details of preillness onset and intermediary stages, and how many additional stages are optimal.


Assuntos
Transtorno Bipolar/diagnóstico , Comitês Consultivos , Biomarcadores/sangue , Transtorno Bipolar/sangue , Progressão da Doença , Humanos , Índice de Gravidade de Doença , Sociedades Médicas
6.
J Affect Disord ; 182: 64-9, 2015 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-25973785

RESUMO

BACKGROUND: Bipolar disorder (BD) is commonly comorbid with many medical disorders including atopy, and appears characterized by progressive social, neurobiological, and functional impairment associated with increasing number of episodes and illness duration. Early and late stages of BD may present different biological features and may therefore require different treatment strategies. Consequently, the aim of this study was to evaluate serum levels of eotaxin/CCL11, eotaxin-2/CCL24, IL-2, IL-4, IL-6, IL-10, IL-17, TNF-α, IFNγ, BDNF, TBARS, carbonyl, and GPx in a sample of euthymic patients with BD at early and late stages compared to controls. METHODS: Early-stage BD patients, 12 late-stage patients, and 25 controls matched for sex and age were selected. 10mL of peripheral blood was drawn from all subjects by venipuncture. Serum levels of BDNF, TBARS, carbonyl content, glutathione-peroxidase activity (GPx), cytokines (IL-2, IL-4, IL-6, IL-10, IL-17, TNF-α and IFNγ), and chemokines (eotaxin/CCL11 and eotaxin-2/CCL24) were measured. RESULTS: There were no demographic differences between patients and controls. No significant differences were found for any of the biomarkers, except chemokine eotaxin/CCL11, whose serum levels were higher in late-stage patients with BD when compared to controls (p=0.022; Mann-Whitney U test). LIMITATIONS: Small number of subjects and use of medication may have influenced in our results. CONCLUSION: The present study suggests a link between biomarkers of atopy and eosinophil function and bipolar disorder. These findings are also in line with progressive biological changes partially mediated by inflammatory imbalance, a process referred to as neuroprogression.


Assuntos
Envelhecimento/sangue , Transtorno Bipolar/sangue , Quimiocina CCL11/sangue , Adulto , Biomarcadores/sangue , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
7.
J Psychiatr Res ; 35(1): 11-4, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11287051

RESUMO

S100B protein, a calcium binding protein produced and released by glial cells, has been used as a sensitive marker of brain damage. Previous studies have found alterations in peripheral S100B levels in schizophrenic patients on medication. We compared serum S100B levels of 20 medication-free DSM-IV schizophrenic patients and 20 age-gender matched healthy controls. Schizophrenic patients presented higher serum S100B levels (mean 0.120 ng/ml+/-S.D. 0.140) compared to controls (mean 0.066 ng/ml+/-S.D. 0.067; P=0.014) and there was a negative correlation with illness duration (r=-0.496, P=0.031). The results of this study indicate that serum S100B levels may be a state marker of a limited neurodegenerative process, particularly in the early course of schizophrenia or, at least, in a subgroup of schizophrenic patients.


Assuntos
Proteínas S100/sangue , Esquizofrenia/metabolismo , Adolescente , Adulto , Encéfalo/metabolismo , Encéfalo/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doenças Neurodegenerativas/metabolismo , Doenças Neurodegenerativas/patologia , Neuroglia/metabolismo
8.
Braz J Biol ; 74(3): 687-90, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25296219

RESUMO

Fishes may show sexual dimorphism according to their reproductive strategies. In some species, this differentiation is already well known. However, with the findings obtained from recent studies, the number of species for which sex can be determined without dissection has increased. Thus far, the presence of external secondary sexual characteristics in Hoplias aimara, a very well-studied species, has not been reported. Traditional knowledge evidenced through riparian people observations indicated the possibility of sexual dimorphism in this species, which was studied in 2 conservation units, Sustainable Development Reserve of Iratapuru River and Tumucumaque Mountains National Park, in the state of Amapá, Brazil. Fishes were captured, and their anal fins were examined when they were still fresh; the sex of the fishes was confirmed by dissection. The same procedure was used for formalin-fixed fishes. By assessing the shape of the anal fin in fresh or fixed fishes, it was possible to determine the sex of the fish, which was then confirmed by dissection. H. aimara shows sexual dimorphism expressed in the morphology of their anal fin. Thus, the sex of fishes deposited in collections can be identified without any dissection, thereby providing important biological information about the specimens.


Assuntos
Nadadeiras de Animais/anatomia & histologia , Caraciformes/anatomia & histologia , Caracteres Sexuais , Animais , Brasil , Caraciformes/classificação , Feminino , Masculino
9.
Neuroscience ; 259: 223-31, 2014 Feb 14.
Artigo em Inglês | MEDLINE | ID: mdl-24316471

RESUMO

Supplementation with omega-3 has been identified as an adjunctive alternative for the treatment of psychiatric disorders, in order to minimize symptoms. Considering the lack of understanding concerning the pathophysiology of schizophrenia, the present study hypothesized that omega 3 prevents the onset of symptoms similar to schizophrenia in young Wistar rats submitted to ketamine treatment. Moreover, the role of oxidative stress in this model was assessed. Omega-3 (0.8g/kg) or vehicle was given by orogastric gavage once daily. Both treatments were performed during 21days, starting at the 30th day of life in young rats. After 14days of treatment with omega-3 or vehicle, a concomitant treatment with saline or ketamine (25mg/kg ip daily) was started and maintained until the last day of the experiment. We evaluated the pre-pulse inhibition of the startle reflex, activity of antioxidant systems and damage to proteins and lipids. Our results demonstrate that supplementation of omega-3 prevented: decreased inhibition of startle reflex, damage to lipids in the hippocampus and striatum and damage to proteins in the prefrontal cortex. Furthermore, these changes are associated with decreased GPx in brain tissues evaluated. Together, our results suggest the prophylactic role of omega-3 against the outcome of symptoms associated with schizophrenia.


Assuntos
Lesões Encefálicas/dietoterapia , Lesões Encefálicas/etiologia , Ácidos Graxos Ômega-3/administração & dosagem , Transtornos Mentais/prevenção & controle , Esquizofrenia/complicações , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Glutationa Peroxidase/metabolismo , Ketamina/toxicidade , Masculino , Malondialdeído/metabolismo , Transtornos Mentais/etiologia , Estresse Oxidativo/efeitos dos fármacos , Carbonilação Proteica/efeitos dos fármacos , Ratos , Ratos Wistar , Esquizofrenia/induzido quimicamente , Esquizofrenia/patologia , Filtro Sensorial/efeitos dos fármacos , Superóxido Dismutase/metabolismo , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo
10.
Neurosci Lett ; 502(3): 143-6, 2011 Sep 20.
Artigo em Inglês | MEDLINE | ID: mdl-21741441

RESUMO

Schizophrenia (SZ) is a chronic severe mental disorder. Increased inflammatory processes have been shown in acute and chronic SZ. Apoptotic processes may alter the neuronal network and are involved in the pathogenesis of several neurodegenerative diseases, such as SZ. Annexin-V seems to have a role on inhibition of pro-inflammatory activities during apoptosis. Tumor necrosis factor (TNF-alpha) is a cytokine involved in systemic inflammation and is a member of a group of cytokines which stimulate acute phase reactions. A chronic immune activation in SZ has been shown. The aim of this study was to compare annexin-V and TNF-alpha serum levels in chronic medicated patients with SZ and healthy controls. Thirty-eight outpatients from the HCPA Schizophrenia Program and 38 healthy controls were enrolled to this study protocol. Annexin-V and TNF-alpha serum levels were measured with ELISA. Serum annexin-V levels were significantly higher in patients with SZ than in controls (p<0.001) and TNF-alpha significantly lower (p<0.001). The present result of increased annexin-V and decreased serum levels of TNF-alpha compared to controls may be a result of the stabilization phase of psychosis and a reduction in metabolic brain aggression. In this complex picture, increased levels of annexin-V and decreased levels of TNF-alpha in our sample would be explained by illness stability and chronic treatment. Our findings support the hypothesis of a state dependant process of inflammation in SZ. Further prospective studies to clarify the findings described in this paper are needed.


Assuntos
Anexina A5/sangue , Antipsicóticos/uso terapêutico , Encéfalo/metabolismo , Esquizofrenia/sangue , Fator de Necrose Tumoral alfa/sangue , Adulto , Anexina A5/fisiologia , Encéfalo/efeitos dos fármacos , Encéfalo/patologia , Doença Crônica , Regulação para Baixo/efeitos dos fármacos , Regulação para Baixo/fisiologia , Metabolismo Energético/efeitos dos fármacos , Metabolismo Energético/fisiologia , Feminino , Humanos , Inflamação/imunologia , Inflamação/metabolismo , Inflamação/patologia , Masculino , Pessoa de Meia-Idade , Esquizofrenia/patologia , Esquizofrenia/terapia , Resultado do Tratamento , Fator de Necrose Tumoral alfa/fisiologia , Regulação para Cima/efeitos dos fármacos , Regulação para Cima/fisiologia
11.
Neurosci Biobehav Rev ; 35(3): 804-17, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20934453

RESUMO

There is now strong evidence of progressive neuropathological processes in bipolar disorder (BD). On this basis, the current understanding of the neurobiology of BD has shifted from an initial focus on monoamines, subsequently including evidence of changes in intracellular second messenger systems and more recently to, incorporating changes in inflammatory cytokines, corticosteroids, neurotrophins, mitochondrial energy generation, oxidative stress and neurogenesis into a more comprehensive model capable of explaining some of the clinical features of BD. These features include progressive shortening of the inter-episode interval with each recurrence, occurring in consort with reduced probability of treatment response as the illness progresses. To this end, emerging data shows that these biomarkers may differ between early and late stages of BD in parallel with stage-related structural and neurocognitive alterations. This understanding facilitates identification of rational therapeutic targets, and the development of novel treatment classes. Additionally, these pathways provide a cogent explanation for the efficacy of seemingly diverse therapies used in BD, that appear to share common effects on oxidative, inflammatory and neurotrophic pathways.


Assuntos
Transtorno Bipolar/fisiopatologia , Inflamação/etiologia , Fatores de Crescimento Neural/metabolismo , Estresse Oxidativo/fisiologia , Animais , Transtorno Bipolar/tratamento farmacológico , Citocinas/metabolismo , Progressão da Doença , Humanos , Fármacos Neuroprotetores/uso terapêutico , Neurotransmissores/metabolismo
12.
J Psychopharmacol ; 23(8): 985-7, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18583441

RESUMO

The psychopathologies underlying affective disorders are thought to involve persistent changes in the expression and function of both mineralocorticoid receptors and glucocorticoid receptors in the hippocampus. In addition, exposure to stressful stimuli can precipitate episodes in vulnerable individuals. The aim of this study is to determine if spironolactone as an adjunctive therapy is effective in improving residual symptoms in bipolar disorder. Four cases of euthymic bipolar disorder (BD) patients were treated with spironolactone as an adjunctive therapy in a private treatment sector. All patients met the DSM-IV diagnosis criteria for bipolar disorder. Clinical response was assessed retrospectively using the Clinical Global Impression Scale for Improvement. Spironolactone was effective in all patients. The four cases illustrate a clinical response to residual symptoms and improvement in stress response after use of spironolactone as an adjunctive therapy in BD. This pilot case series suggests reducing in residual symptoms, with spironolactone as an adjunctive therapy in these DSM-IV BD patients. Mineralocorticoid receptors antagonists' role in reducing stress-induced symptoms deserves further investigation through placebo-controlled trials.


Assuntos
Transtorno Bipolar/tratamento farmacológico , Antagonistas de Receptores de Mineralocorticoides , Espironolactona/uso terapêutico , Estresse Psicológico/tratamento farmacológico , Adulto , Transtorno Bipolar/psicologia , Feminino , Humanos , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Sistema Hipófise-Suprarrenal/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa